{"classes":[{"categories":[{"measurements":[{"comment":"95% confidence - 9.7 months to not reached","groupId":"OG000","lowerLimit":"9.7","upperLimit":"NA","value":"13.9"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"}],"units":"Participants"}],"dispersionType":"95% Confidence Interval","groups":[{"description":"Patients will receive sunitinib by mouth once a day. Treatment may continue for as long as benefit is shown.\n\nsunitinib malate: Given orally","id":"OG000","title":"Arm I"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"At 6 months and 1 year","title":"Overall Survival","type":"SECONDARY","unitOfMeasure":"months"}